Foresite Capital Management V, LLC Pharvaris N.V. Transaction History

Foresite Capital Management V, LLC

  • $43.4 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
SELL
$14.68 - $21.4 $14,680 - $21,400
-1,000 Reduced 2.93%
33,142 $691,000
Q4 2021

Feb 11, 2022
SELL
$13.28 - $18.0 $4.38 Million - $5.94 Million
-330,000 Reduced 90.62%
34,142 $491,000
Q2 2021

Aug 16, 2021
SELL
$18.05 - $29.59 $5.42 Million - $8.88 Million
-300,000 Reduced 45.17%
364,142 $6.78 Million
Q1 2021

May 17, 2021
BUY
$25.25 - $40.11 $16.8 Million - $26.6 Million
664,142 New
664,142 $18.6 Million

Others Institutions Holding PHVS

# of Institutions
51
Shares Held
39.6M
Call Options Held
0
Put Options Held
0
View Full List

About Pharvaris N.V.

PHVS Quotes by TradingView
  • Ticker PHVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,766,000
  • Market Cap $636M
  • Description
  • Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...
More about PHVS
Track This Portfolio

Track Foresite Capital Management V, LLC Portfolio

Follow Foresite Capital Management V, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresite Capital Management V, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foresite Capital Management V, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email